A non-invasive urinary diagnostic signature for diabetic kidney disease revealed by machine learning and single-cell analysis
PLOS One · 2026
DOI: 10.1371/journal.pone.0340096 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Yonggang Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Loudi Central Hospital, Loudi, Hunan Province, China. Hauptthemen laut MEDLINE: Machine Learning, Diabetic Nephropathies, Single-Cell Analysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Diabetic kidney disease (DKD) poses a significant health burden with inadequate diagnostic sensitivity. This study develops non-invasive biomarkers by integrating urinary and renal single-cell sequencing with machine learning.
Methods
This study analyzed DKD single-cell and bulk transcriptomic data from public repositories. We established a computational pipeline to distinguish kidney-originating cells in urinary sediments, enabling the identification of injury-associated gene signatures. These signatures were refined using machine learning to develop a diagnostic model, which was validated in independent cohorts. The biomarkers were further verified in DKD renal tissues at single-cell resolution and across multiple nephropathies. Functional and spatial analyses confirmed biological relevance using transcriptomic and histological validation.
Results
Single-cell analysis of 2,089 urine-derived cells identified eight renal cell types, including injured proximal tubule cells (Inj-PTC) showing upregulated injury markers (HAVCR1, VCAM1) and enriched apoptotic/TGF-β pathways. A machine learning-selected biomarker panel (PDK4, RHCG, FBP1) demonstrated strong diagnostic value (area under the curve, AUC > 0.9), with consistent downregulation across multiple chronic kidney diseases. PDK4 and FBP1 were specifically suppressed in DKD renal Inj-PTC (p < 0.05). Functional analyses revealed their involvement in glucose metabolic pathways, and their cell type-specific expression patterns were confirmed by transcriptomic and immunohistochemical data.
Conclusions
This study identifies a three-gene biomarker panel (PDK4, RHCG, FBP1) as a promising non-invasive diagnostic tool for DKD. While demonstrating excellent diagnostic performance. It represents a tubular injury-associated gene signature that is detectable in urinary cells and shows strong association with DKD in transcriptomic datasets, presenting a promising candidate for a non-invasive diagnostic assay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Loudi Central Hospital, Loudi, Hunan Province, China.
- Department of Urology and Andrology, Minimally Invasive Surgery Center, Guangdong Provincial Key Laboratory of Urology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
- Loudi Hospital, First Affiliated Hospital of Guangzhou Medical University, Loudi, Hunan Province, China.
- Fangchenggang Hospital of Traditional Chinese Medicine, Guangxi University of Chinese Medicine, Fangchenggang, Guangxi, China.
- Department of Cardiovascular Medicine, Loudi Central Hospital, Loudi, Hunan Province, China.
ORCID-Profile: Yonggang Chen
Zitieren
APA
Chen, Y., Luo, J., Zheng, Y., Jiang, X., Yang, Z., & Liu, X. (2026). A non-invasive urinary diagnostic signature for diabetic kidney disease revealed by machine learning and single-cell analysis. PLOS One. https://doi.org/10.1371/journal.pone.0340096
Vancouver
Chen Y, Luo J, Zheng Y, Jiang X, Yang Z, Liu X. A non-invasive urinary diagnostic signature for diabetic kidney disease revealed by machine learning and single-cell analysis. PLOS One. 2026. doi:10.1371/journal.pone.0340096
BibTeX
@article{Chen2026,
author = {Chen, Yonggang and Luo, Jintai and Zheng, Yingying and Jiang, Xiaomei and Yang, Zixiang and Liu, Xiaobing},
title = {A non-invasive urinary diagnostic signature for diabetic kidney disease revealed by machine learning and single-cell analysis},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0340096}
}
EUVIMED